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Abstract We have investigated the effect of botulinum neuro-
toxin (BoNT) Cl light chain (LC) on insulin exocytosis from the 
clonai ß-cell line HIT-T15. In streptolysin-O permeabilized cells, 
the ß-cell impermeant BoNT Cl cleaved mainly syntaxin 1 and 
inhibited Ca + as well as GTP7S induced exocytosis. To study 
the effect of BoNTs in intact cells, we transiently coexpressed the 
BoNT LC together with a reporter gene for insulin release. 
BoNT Cl inhibited K+ induced insulin secretion by 95% but 
reduced insulin release stimulated by glucose only by 25%. Thus 
a component of glucose stimulated insulin release is insensitive to 
BoNT Cl. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Alterations in cytosolic levels of the second messenger Ca2+ 
control regulated secretion by exocytosis in neuronal and en-
docrine cells [1-3]. In the pancreatic ß-cells glucose metabo-
lism causes insulin secretion from large dense core vesicles 
(LDCV) by two mechanisms. First, exposure of ß-cells to 
the sugar induces closure of ATP-sensitive K+ (КДТР) chan-
nels with subsequent membrane depolarization and voltage 
dependent Ca2+ influx [1]. The ensuing increase in cytosolic 
Ca2+ [Ca2+]c evokes insulin release [1,3]. Second, glucose fur-
ther enhances Ca2+ induced insulin secretion by a mechanism 
distinct from closure of KATP channels, alterations in [Ca2+]c 
or activation of protein kinases A or С [4]. This second path-
way, however, requires stimulatory levels of [Ca2+]c [4,5] and 
is completely inhibited by Ca2+ channel blockers [4]. 
The mechanism of the KATP independent glucose effect on 
exocytosis has not yet been identified. Molecular dissection of 
the general exocytotic process in yeast, flies and mammals has 
prompted the SNARE hypothesis to summarize the detailed 
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molecular events [6,7]. Exocytosis requires the assembly of the 
membrane proteins syntaxin, SNAP-25 and synaptobrevin/ 
VAMP to a multi-subunit aggregate, the SNARE complex, 
which subsequently binds the cytosolic components NSF 
(NEM sensitive factor) and oi/ß-SNAP. The role of SNARE 
complex proteins in Ca2+ induced neurotransmitter release 
and neuroendocrine secretion has been confirmed by the cor-
relation between their selective cleavage and the blockade of 
exocytosis by clostridial neurotoxins [8,9]. Tetanus toxin and 
botulinum neurotoxin (BoNT) B, D, F and G proteolyse spe-
cifically VAMP/cellubrevin, whereas BoNT A and E cleave 
SNAP-25. BoNT Cl acts on syntaxin (isoforms 1A, IB and 
2) and in addition on SNAP-25 [10-12]. 
In pancreatic ß-cells several isoforms of the major compo-
nents of the exocytotic machinery have been identified previ-
ously [13,17]. More importantly, their functional implication 
has been demonstrated for VAMP/synaptobrevin and SNAP-
25 using the ß-cell impermeant clostridial neurotoxins in 
streptolysin-O (SL-O) permeabilized cells [14,15,18]. 
The function of the SNARE protein syntaxin is less evident 
in ß-cells. Employing anti-syntaxin antibodies or peptides cor-
responding to a helical domain of syntaxin 1 a role of syntax-
in in Ca2+ induced insulin exocytosis was deduced [19,20]. As 
overexpression of syntaxin 1A in the clonai ß-cell line ßTC3 
suppressed glucose stimulated exocytosis, syntaxin 1A was 
proposed as a negative regulator in insulin exocytosis [21]. 
Therefore we have investigated the effect of the ß-cell imper-
meant BoNTs Cl and E on insulin exocytosis. Furthermore, 
we report a method which permits the use of the cell imper-
meant BoNTs in intact cells. 
2. Materials and methods 
2.1. Materials 
Recombinant pore forming toxins were kindly provided by Dr U. 
Weiler (Mainz, Germany) and recombinant clostridial neurotoxins 
were produced by standard procedures in Escherichia coli. pEGFP 
was purchased from Clontech (Heidelberg, Germany). mAb anti-
VAMP, polyclonal anti-SNAP-25 and polyclonal anti-BoNT Cl light 
chain (LC) were generously provided by Dr. R. Jahn (MPI Göttingen, 
Germany), Dr. C. Montecucco (Padua, Italy) and Dr. S. Kozaki 
(Osaka, Japan), respectively. To construct peGFP/BoNT Cl, the 
EcoRl/Pstl fragment of pQE/BoNT Cl LC was inserted into the 
same cleavage sites of peGFP-C2. 
2.2. Cell culture, transient cotransfection, FACS and 
immunofluorescencelimmunoblots 
HIT-T15 cells were cultured, transiently cotransfected and purified 
by fluorescent activated cell sorting as published [17,22,23]. Western 
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blots and immunofluorescence were performed as described previously 
[17]. Primary antibodies were used at the following dilutions: anti-
syntaxin (Sigma) 1:4000; mAb anti-SNAP-25 C-terminus (Sternber-
ger Monoclonals, Baltimore, MD, USA) 1:2000; mAb anti-VAMP 
1:10000; polyclonal anti-SNAP-25 N-terminus 1:1000 [12]. 
2.3. Cell permeabilization 
Preparation of intracellular buffers and permeabilization procedures 
were as described [5,17,22,23]. Na2ATP (5 mM) was present through-
out the experiment. BoNTs were added to the permeabilized cells only 
during 9 min preincubation in intracellular buffer at 0.1 μΜ free 
Ca2+. Subsequently, this solution was exchanged for intracellular buff-
er containing the indicated concentrations of free Ca2+ or 0.1 μΜ free 
Ca2+ and 100 μΜ GTPyS (Boehringer, Rotkreuz, Switzerland) in the 
absence of BoNTs [16,17,22]. 
2.4. Statistical analysis 
Results are presented as mean ± S.D. from experiments performed 
independently on at least three different cell preparations. Statistical 
analysis was performed by Student's two-tailed i-test for unpaired 
data (2p) if not stated otherwise. 
Fig. 2. BoNT CI LC expression and SNARE protein cleavage by 
transiently expressed BoNT Cl LC in intact cells. A: BoNT CI LC 
expression. Cells cotransfected with phlNS and pcDNA3 (CON) or 
with phlNS and pCMV/BoNT CI LC (LCC) were homogenized, 
separated into supernatant (SUP) and particulate fraction (P) by 
centrifugation (14000Xg, 30 min) and immunoblots performed with 
a polyclonal antibody against BoNT Cl LC. B: Cells were trans-
fected with peGFP/BoNT Cl or cotransfected with peGFP and 
pCMV/BoNT E LC and sorted by FACS. Aliquots of sorted cells 
(0.5 X105/lane) were subjected to SDS-PAGE followed by immuno-
blot. CON, control, C, peGFP/BoNT Cl transfected positive cells; 
E, pCMV/BoNT E LC positive cells. Syntaxin, mAb anti-syntaxin; 
SNAP-25 m, monoclonal anti-SNAP-25 antibody; SNAP-25 p, poly-
clonal anti-SNAP-25 C-terminus antibody. The blot shown is repre-
sentative of three independent experiments. 
3. Results and discussion 
Fig. 1. Effect of BoNT Cl light chain on SNARE cleavage and in-
sulin exocytosis in SL-0 permeabilized HIT-T15 cells. A: HIT-T15 
cells were permeabilized with SL-O and incubated for 9 min with 
the indicated concentrations of BoNT Cl or with 2 nM BoNT E. 
Subsequently cells were homogenized, separated by SDS/PAGE and 
immunoblots performed (1X 105/lane) with antibodies recognising 
intact syntaxin 1, SNAP-25 C-terminus (SNAP-25) or VAMP. 
B: Effect of BoNTC 1 pretreatment in SL-O permeabilized cells on 
subsequent exocytosis stimulated by Ca2+ or GTPyS. The difference 
between 0.1 and 10 μΜ CA2+ (filled symbols) or 0.1 μΜ CA2+ in 
the absence or presence of 100 μΜ GTPyS (open symbols) in the 
controls was normalized to 100%. Bars: effect of 2 nM BoNT E on 
exocytosis stimulated by Ca2+ (filled bar) or GTPyS (open bar). 
л = 6—18 from four independent experiments. 
3.1. Effect of BoNTs Cl and E in permeabilized cells 
We first examined the acute effect of BoNT C l on S N A R E 
protein cleavage. In contrast to neurons and chromaffin cells, 
ß-cells are impermeant to clostridial neurotoxins. Therefore, 
HIT-T15 cells were permeabilized by SL-O [16,17,22,23]. 
Under these conditions, BoNT C l L C cleaved syntaxin 1 in 
a dose dependent manner (see Fig. 1A). SNAP-25 immuno-
reactivity was detected with a polyclonal C-terminally directed 
antibody, which only recognizes the uncleaved protein [12]. A 
decrease in SNAP-25 levels occurred only at BoNT C l con-
centrations above 10 n M . In contrast, 2 n M BoNT E mark-
edly reduced SNAP-25 immunoreactivity. As expected, none 
of the toxins altered the amount of the S N A R E VAMP/syn-
aptobrevin. Pretreatment of SL-O permeabilized cells by 
B o N T C l LC did not influence the basal release of insulin 
at 0.1 μ Μ Ca 2 + (8.7 ± 1 . 3 ng insulin/well in the absence of 
B o N T Cl LC versus 7.8 ± 1.6 ng in the presence of 100 n M 
B o N T C l LC, л = 9-14). Exposing permeabilized cells to 
10 μ Μ Ca 2 + , the maximal stimulatory Ca 2 + concentration 
[3,17,22,23], or 100 μ Μ GTPyS [16] increased insulin release 
4-7- and 2-3-fold, respectively. For a better comparison be-
tween the two stimuli, the release over basal evoked by 10 μΜ 
C a 2 + or by GTPys in the absence of BoNT C l LC was nor-
malized to 100%. Exocytosis evoked by Ca 2 + or GTPyS was 
inhibited to a similar extent by B o N T C l (Fig. IB). Half-
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Fig. 3. Syntaxin, SNAP-25 and insulin immunoreactivity in HIT-
T15 cells transiently expressing BoNT Cl LC or BoNT E LC. Cells 
transiently transfected with peGFP/BoNT CI (Cl) or with peGFP 
and pCMV/BoNTE LC (E) were fixed, permeabilized and stained 
with anti-insulin (INS, 1:200), anti-syntaxin (SYX, 1:100) or poly-
clonal anti-SNAP-25 C-terminus (SNAP, 1:100) antibodies. Anti-
bodies used and type of transiently expressed toxins are given on 
the left. Left panel: eGFP fluorescence; middle panel: antibody 
binding as revealed by rhodamine coupled second antibodies; right 
panel: phase contrast with arrows indicating eGFP expressing cells. 
only intact SNAP-25 [12], did not reveal a major change be-
tween homogenates from control cells or those expressing 
BoNT CI LC. For comparison we immunoblotted homoge-
nates from purified cells expressing BoNT E. In this case, a 
reduction or cleavage of SNAP-25 was clearly visible. 
We confirmed these observations by immunofluorescence of 
cotransfected cells. The amount of insulin and the distribution 
of secretory granules were not altered by the expression of 
peGFP/BoNT CI LC (Fig. 3). Again, the expression of 
BoNT Cl LC resulted in a loss of syntaxin 1 immunoreactiv-
ity, whereas a change in SNAP-25 immunoreactivity was not 
detected (Fig. 3). In contrast, the coexpression of BoNT E LC 
and eGFP led to a complete loss of SNAP-25 immunoreac-
tivity in GFP positive cells (Fig. 3). 
There is no obvious explanation for the difference in BoNT 
Cl produced SNARE cleavage between neurons and chro-
maffin cells on the one hand [10-12] and endocrine ß-cells 
on the other. The two recently identified SNAP-25 isoforms 
SNAP-23 and syndet [27,28] have a broad tissue distribution 
and may be resistant to BoNT Cl. However, the anti-SNAP-
25 antibodies used here did not cross-react with GST-syndet 
or GST-SNAP-23 (data not shown), excluding the possibility 
that such a cross-reactivity could have masked SNAP-25 
cleavage. It is of interest that experiments using BoNT Cl 
in cultured dorsal root ganglia also did not reveal SNAP-25 
cleavage [29]. This may suggest a high degree of cell specificity 
in the action of BoNT Cl on SNAP-25. Alternatively, the 
amount of BoNT Cl LC expressed was rather small and 
perhaps only sufficient to cleave syntaxin. The latter is in 
agreement with our results in permeabilized cells indicating 
that syntaxin is more sensitive to BoNT Cl LC than SNAP-
25. 
maximal inhibition was apparent at 10 nM BoNT CI LC, a 
toxin concentration which did not reduce SNAP-25 levels (see 
Fig. 1A). Ca2+ or GTPyS induced exocytosis was also abol-
ished by BoNT E LC (Fig. IB). These data indicate that both 
pathways leading to exocytosis require the SNARE proteins 
syntaxin and SNAP-25 in HIT-T15 cells. 
Although SL-O permeabilized cells offer a useful model to 
study exocytosis [23,24], the final step in the secretory path-
way, permeabilized cells preclude a number of interesting 
studies. We therefore transiently expressed clostridial neuro-
toxin light chains in clonai ß-cells thereby providing a defined 
intracellular source as demonstrated previously for tetanus 
toxin [25,26]. Using a polyclonal antibody against BoNT Cl 
LC we found specific expression of the toxin in homogenates 
and the soluble fraction of transiently transfected cells, but 
not in the membrane pellet or in untransfected cells (Fig. 2A). 
To study BoNT induced cleavage of SNAREs in HIT-T15 
cells, we transiently expressed green fluorescent protein 
(eGFP) fused in frame with BoNT Cl LC (peGFP/BoNT 
Cl) or eGFP and BoNT E. The cells expressing BoNTs 
were purified by fluorescent activated cell sorting and the 
SNARE proteins syntaxin and SNAP-25 were examined by 
immunoblotting (see Fig. 2). As expected, we observed a large 
reduction in syntaxin immunoreactivity in homogenates from 
sorted cells expressing BoNT Cl LC. In contrast, we could 
not detect cleavage in SNAP-25 using a monoclonal C-termi-
nal antibody, which still recognizes the truncated form [15]. 
Likewise, a polyclonal C-terminal antibody, which detects 
Fig. 4. Effect of transient expression of BoNT Cl LC on human in-
sulin С peptide secretion from intact cells. Cells were cotransfected 
with phlNS and either pcDNA3 (open bars), pCMV/BoNT Cl LC 
(filled bars) or pCMV/BoNT E LC (hatched bars) as given in Sec-
tion 2 and 48 h later exposed for 15 min to KRB without glucose 
(BASAL), 48 mM KC1 (KCL), 100 nM of the phorbol ester PMA 
together with 10 μΜ forskolin and 0.5 mM IBMX (PMA/FORS), 
5 mM glucose (GLU), 30 mM KC1/250 μΜ diazoxide (KCL/DZ), 
or 30 mM KC1/250 μΜ diazoxide/5 mM glucose (KCL/DZ/GLU). 
л = 6-12; + 1P<0.05; *2P<0.05 as compared to the absence of 
toxins. 
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3.2. Transient expression of BoNT Cl or E and insulin 
secretion from intact cells 
Having established the expression of BoNT Cl and E LC, 
their effect on insulin release was studied. For this purpose, 
cells were cotransfected with pCMV/BoNT С or E and a 
plasmid encoding human insulin (phlNS) as reporter gene 
for exocytosis in the hamster insulin secreting cell line HIT-
T15. This permits the study of hormone release exclusively 
from cotransfected cells [17,22,23,30]. First, we tested whether 
expression of BoNT CI LC inhibits exocytosis similar to the 
acute effects of recombinant toxin in SL-O permeabilized cells 
described above. To create small pores preventing the leakage 
of expressed BoNT CI LC or BoNT E LC, cotransfected cells 
were permeabilized with α-toxin from Staphylococcus aureus 
[5,16,24]. Under this condition, GTPyS or 10 μΜ Са2+ in-
creased hormone release in control cells (cotransfected with 
phlNS and pcDNA3) by 845 ±33% and 1686181%, respec-
tively (n-6 for each condition). Cotransfection with phlNS 
and pCMV/BoNT Cl LC resulted in 91.3 ± 5.5% inhibition of 
GTPyS induced exocytosis and 95.1 ± 2.4% inhibition of Ca2+ 
evoked exocytosis (n = 6 for each condition). A comparable 
inhibition of exocytosis by both stimuli was observed after 
coexpression of human insulin and BoNT E LC. For both 
toxins human insulin C-peptide content and C-peptide release 
at 0.1 μΜ Ca2+ remained unchanged (data not shown). 
Next, we stimulated insulin secretion in intact HIT-T15 
cells by activation of different pathways. Exposure of intact 
cells to KC1 leads to membrane depolarization and voltage 
dependent Ca2+ influx triggering secretion in primary β- and 
clonai HIT-T15 cells [3]. As shown in Fig. 4, KC1 induced 
insulin release was completely inhibited in intact HIT-T15 
cells by expression of BoNT С or E LC. A similar effect 
was observed after stimulation of insulin release by combined 
activation of the protein kinases A and С through forskolin/ 
IBMX and the phorbol ester PMA. In contrast, BoNT Cl LC 
diminished by only 25%> insulin release induced by glucose, 
whereas BoNT E LC expression resulted in complete inhib-
ition (Fig. 4). Glucose evokes insulin secretion not only 
through closure of KATP channels followed by membrane de-
polarization and voltage dependent Ca2+ influx, but also 
through a pathway independent of KATP channels. The effect 
of the sugar on KATP channels and [Ca2+]c in primary ß-cells 
can be circumvented by the use of diazoxide to keep KATP 
channels open and КС1 to induce membrane depolarization 
resulting in voltage dependent Ca2+ influx. Under these con-
ditions of raised [Ca2+]c, glucose still produces a further in-
crease in insulin release [4]. This involves a pathway distinct 
from further changes in [Ca2+]c or activation of protein ki-
nases A and C. To validate the resistance of glucose mediated 
secretion to BoNT Cl LC, we used a similar protocol. As 
shown in Fig. 4, the concomitant presence of glucose further 
enhanced the insulin release stimulated by KCl/diazoxide in 
HIT-T15 cells. Whereas stimulation by KCl/diazoxide alone 
was abolished by BoNT CI LC, a lesser degree of inhibition 
by BoNT Cl LC was observed when KCl/diazoxide was 
added in the presence of glucose. 
These findings allow two main conclusions. First, functional 
syntaxin is required for Ca2+ evoked insulin release from 
LDCVs. The previously reported inhibitory role of overex-
pressed syntaxin 1A [21] may reflect scavenging of interacting 
SNARE proteins as also observed for VAMP [30]. Results 
based on overexpression can therefore not be taken per se 
as evidence of an inhibitory role of syntaxin. Indeed, in 
HIT-T15 cells large overexpression of syntaxin 1A produced 
similar inhibition (unpublished observations). 
Second, an alternative pathway to exocytosis must exist, as 
a component of glucose induced insulin release is insensitive 
to BoNT Cl. Increased levels of [Ca2+]c are necessary to ob-
serve the KATP independent effect of glucose [4,5,31]. The 
Ca2+ requirement could reflect presensitization of exocytosis 
necessary to observe KATP independent glucose effects. Alter-
natively, the well-documented requirement of Ca2+ influx for 
glucose induced insulin secretion [1,3,31] may reflect an addi-
tional action of Ca2+ at sites distinct from exocytosis itself. 
Indeed, glucose has to be metabolized to elicit its secretory 
response [32] which involves several Ca2+ sensitive mitochon-
drial enzymes [5,33-35]. As transient expression of BoNT LCs 
did not alter the content or basal release of the reporter gene 
(human insulin C-peptide), effects on the biosynthetic path-
way prior to exocytosis can be excluded. Interestingly an al-
ternative pathway to exocytosis has also been suggested to be 
present in insulin secreting RINm5F cells, in which BoNT В 
and F cleave synaptobrevin/VAMP but do not inhibit depo-
larization induced exocytosis [36]. 
Our observations do not negate a role of Ca2+ regulated 
and BoNT Cl sensitive components of the exocytotic machin-
ery in the initial period of glucose stimulated insulin secretion. 
The partial inhibition of glucose induced exocytosis by BoNT 
Cl may be caused by the toxin effect on this initial phase of 
insulin release. This point could not be directly addressed in 
this study due to the limited time resolution inherent in the 
biochemical assays and the levels of reporter gene expression. 
It is conceivable that more subtle events such as rapid hor-
mone release, colocalization of secretory granules with Ca2+ 
influx sites [37] or pulsatility of secretion [38] are altered by 
the action of BoNT Cl. 
The present data demonstrate the usefulness of transiently 
expressed BoNT Cl to study the role of SNARE proteins in 
toxin impermeant intact cells. This approach is likely to be 
applicable to most of the clostridial neurotoxins. Future work 
should determine whether glucose induced exocytosis involves 
BoNT Cl resistant isoforms of syntaxin [39,40] or proceeds by 
a mechanism independent of syntaxin. 
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